RemeGen Co. Ltd. Class A
688331
Classement en actions
#2419
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces,... RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Prix de l'action
$14.49
Capitalisation boursière
$8.11B
Changement (1 jour)
2.99%
Changement (1 an)
9.18%
Pays
CN
Échange RemeGen Co. Ltd. Class A (688331)
Catégorie
Healthcare
Historique des divisions d’actions pour RemeGen Co. Ltd. Class A (688331)
L’action RemeGen Co. Ltd. Class A (symbole : 688331) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action 688331 achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions 688331.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action 688331 achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions 688331.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| Pas assez de données pour les dates fournies. | |||
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
